BRD4 and leukemia: This compound demonstrated significant efficacy in terms of inhibiting BRD4, with an IC50 value of 9.4 nM, and effectively suppressed cell proliferation in the BRD4-sensitive RS4;11 leukemia cell line, with an IC50 value of 27.6 nM.